175 related articles for article (PubMed ID: 4477555)
1. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF
Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555
[No Abstract] [Full Text] [Related]
2. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated cytotoxicity against human bladder cancer.
Bloom ET; Ossorio RC; Brosman SA
Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
[No Abstract] [Full Text] [Related]
4. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
[No Abstract] [Full Text] [Related]
5. In vitro cytotoxicity studies in bladder and renal cell cancer.
Elhilali MM; Nayak SK
Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
[TBL] [Abstract][Full Text] [Related]
6. Immunologic features of genitourinary cancer.
Javadpour N
Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
[No Abstract] [Full Text] [Related]
7. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.
Hakala TR; Lange PH; Castro A; Elliott A; Fraley EE
Cancer; 1974 Dec; 34(6):1929-34. PubMed ID: 4434325
[No Abstract] [Full Text] [Related]
8. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
Hakala TR
Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
10. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
Hakala TR; Lange PH
Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
[TBL] [Abstract][Full Text] [Related]
11. Immunobiology of genitourinary tumors.
Lange PH; Hakala TR; Fraley EE
Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
[No Abstract] [Full Text] [Related]
12. In vitro augmentation of cytotoxicity against tumor cell lines by mumps virus.
Morales A; Ottenhof P; Elliott M
Invest Urol; 1980 Jan; 17(4):284-7. PubMed ID: 6927978
[TBL] [Abstract][Full Text] [Related]
13. Prelabeling target cells with 3 H-proline as a method for studying lymphocyte cytotoxicity.
Bean MA; Pees H; Rosen G; Oettgen HF
Natl Cancer Inst Monogr; 1973 Jun; 37():41-8. PubMed ID: 4713785
[No Abstract] [Full Text] [Related]
14. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
Catalona WJ; Chretien PB; Trahan EE
J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
[No Abstract] [Full Text] [Related]
15. Carcinoembryonic antigen in patients with urologic cancers.
Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
[No Abstract] [Full Text] [Related]
16. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
Morales A
Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
[TBL] [Abstract][Full Text] [Related]
17. Defective monocyte chemotactic response in genitourinary carcinoma.
Brosman S; Hausman MS
Urology; 1974 Aug; 4(2):129-34. PubMed ID: 4851277
[No Abstract] [Full Text] [Related]
18. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
Surg Forum; 1975; 26():122-4. PubMed ID: 56048
[No Abstract] [Full Text] [Related]
19. A modification of the (75Se) selenomethionine assay for the detection of complement-dependent antibody in human tumor systems.
Avis IL; Avis FP
J Surg Oncol; 1983 Apr; 22(4):231-5. PubMed ID: 6834843
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?
O'Toole C; Perlmann P; Wigzell H; Unsgaard B; Zetterlund CG
Lancet; 1973 May; 1(7812):1085-8. PubMed ID: 4123535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
